The Wire · All news

Ozempic / GLP-1 Lawsuits

FDA Flags GLP-1 Pens That May Contain No Medication; New Research Examines Additional Risks

Published Updated

By People's Justice

What happened

According to a report from MedShadow Foundation, the FDA issued a warning that some GLP-1 receptor agonist pens may contain no medication. The report was published alongside separate coverage of ongoing gastroparesis litigation and new peer-reviewed research examining GLP-1 drugs and bipolar disorder hospitalization, pregnancy complications, and orofacial adverse events.

Event date:

Source: news.google.com

Related news

  1. Ozempic / GLP-1 Lawsuits

  2. Ozempic / GLP-1 Lawsuits

    Search Interest in Ozempic Recalls and Side Effects Surges

    Google Trends data recorded sharp week-over-week increases in searches for terms including "ozempic news" (up 750%), "ozempic news today" (up 950%), "ozempic recall 2025" (up 130%), and "side effects of semaglutide" (up 350%), along with breakout interest in "what is ozempic 2.0." This reflects rising public search activity, not a confirmed regulatory, legal, or court development.

    Source: trends.google.com

  3. Ozempic / GLP-1 Lawsuits

    Public Search Interest in Ozempic Side Effects and Recalls Rises Sharply

    Google Trends data recorded a sharp week-over-week rise in searches for terms including "ozempic news today" (up 950%), "ozempic news" (up 750%), "ozempic recall 2025" (up 130%), and related side-effect searches such as "common side effects of ozempic" and "side effects of semaglutide" (each up 350%). Several terms, including "what is ozempic 2.0" and "pet food recall news," registered as Google Trends "breakout" searches, indicating unusually large increases in volume.

    Source: trends.google.com